Live feed11:00:00·64dPRReleaseNew Case Study Highlights Ability of bioAffinity Technologies' CyPath® Lung to Reduce Diagnostic Burden for Patients At Risk for Lung CancerBIAF· bioAffinity Technologies Inc.Health CareOriginal source
